May 13 |
Invivyd, Inc. (NASDAQ:IVVD) Q1 2024 Earnings Call Transcript
|
May 12 |
With 31% stake, Invivyd, Inc. (NASDAQ:IVVD) seems to have captured institutional investors' interest
|
May 12 |
Invivyd, Inc. (IVVD) Q1 2024 Earnings Call Transcript
|
May 10 |
Invivyd Inc (IVVD) Reports Q1 2024 Financial Results: A Detailed Analysis
|
May 9 |
Invivyd GAAP EPS of -$0.38 beats by $0.13
|
May 9 |
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
May 7 |
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
|
May 2 |
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
|
Apr 30 |
Invivyd cuts 14 positions, expects to end 2024 with at least $75M in cash
|
Apr 30 |
Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
|